Get the Stockscreener App
4.52
4.39%
0.19
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Forecast
The Corbus Pharmaceuticals Holdings Inc (CRBP) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $5.5795, representing a +23.44% increase from the current price of $4.52. The highest analyst price target is $9.561, and the lowest is $1.598.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CRBP Price Target
Average 7.8969
(+74.71% Upside)
Is Corbus Pharmaceuticals Holdings Inc (CRBP) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 21.73 | Buy |
| STOCH(9,6) | 7.8016 | Buy |
| STOCHRSI(14) | 32.13 | Neutral |
| MACD(12,26) | -1.0834 | Sell |
| ADX(14) | 56.68 | Sell |
| William %R | -89.40 | Buy |
| CCI(14) | -66.15 | Neutral |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.108
Sell
|
5.1214
Sell
|
| MA20 |
6.0888
Sell
|
5.9634
Sell
|
| MA50 |
8.3198
Sell
|
7.4306
Sell
|
| MA100 |
8.4775
Sell
|
8.258
Sell
|
| MA200 |
8.8154
Sell
|
8.9521
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CRBP could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on CRBP, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 21.73 indicates that CRBP is oversold. This indicates that CRBP price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 7.8016 indicates that CRBP is oversold. This indicates that CRBP price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 32.13 indicates that CRBP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 56.68 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -66.15 indicates that CRBP is still oversold but not to an extreme extent.
Long-term CRBP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Corbus Pharmaceuticals Holdings Inc financial reports and earnings history, Corbus Pharmaceuticals Holdings Inc (CRBP) stock could reach $49.39 by 2030, $43.27 by 2040 and $99.46 by 2050. See the projected annual prices until 2050 of the Corbus Pharmaceuticals Holdings Inc stock below:
- Corbus Pharmaceuticals Holdings Inc (CRBP) is expected to reach an average price of $7.1056 in 2035, with a high prediction of $22.50 and a low estimate of $5.3326. This indicates an $57.20% rise from the last recorded price of $4.52.
- Corbus Pharmaceuticals Holdings Inc (CRBP) stock is projected to chart a bullish course in 2040, with an average price target of $44.03, representing an $874.13% surge from its current level. The forecast ranges from a conservative $43.59 to a sky-high $43.27.
- Our analysts predict Corbus Pharmaceuticals Holdings Inc (CRBP) to jump 1,525% by 2045, soaring from $73.81 to an average price of $73.45, potentially reaching $74.39. While $73.81 is the low estimate, the potential upside is significant.
- Corbus Pharmaceuticals Holdings Inc (CRBP) stock is expected to climb by 2050, reaching an average of $99.19, a $2,094% jump from its current level. However, a wide range of estimates exists, with high and low targets of $99.46 and $99.37, respectively, highlighting the market's uncertainty.
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Year by Year Forecast
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Price Forecast for 2026
The predicted value for Corbus Pharmaceuticals Holdings Inc (CRBP) in 2026 is set at an average of $7.2394. Estimates vary from a peak of $12.88 to a trough of $1.598, indicating an +60.16% surge from the present price of $4.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $2.303 | $1.598 | $9.561 | -49.05% |
| December, 2026 | $2.3279 | $2.435 | $2.8845 | -48.50% |
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Corbus Pharmaceuticals Holdings Inc (CRBP) is $10.62, with a high forecast of $15.72 and a low forecast of $5.5114. This indicates an +134.85% increase from the last price of $4.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $9.0439 | $5.5114 | $6.5539 | +100.09% |
| February, 2027 | $11.35 | $10.59 | $9.6489 | +151.10% |
| March, 2027 | $10.47 | $12.36 | $12.08 | +131.58% |
| April, 2027 | $6.1644 | $6.2604 | $8.5689 | +36.38% |
| May, 2027 | $13.03 | $10.15 | $11.32 | +188.29% |
| June, 2027 | $12.44 | $12.91 | $12.46 | +175.33% |
| July, 2027 | $13.72 | $13.31 | $12.34 | +203.51% |
| August, 2027 | $12.50 | $12.83 | $12.82 | +176.55% |
| September, 2027 | $14.23 | $13.22 | $12.63 | +214.83% |
| October, 2027 | $14.21 | $14.41 | $14.20 | +214.41% |
| November, 2027 | $16.44 | $14.64 | $15.24 | +263.71% |
| December, 2027 | $15.96 | $16.14 | $15.72 | +253.07% |
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Price Forecast for 2028
In 2028, Corbus Pharmaceuticals Holdings Inc (CRBP) is projected to reach an average price of $11.74, with a high projection of $15.71 and a low estimate of $7.7685. This indicates an +159.66% rise from the last price of $4.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $15.49 | $16.13 | $15.71 | +242.70% |
| February, 2028 | $15.83 | $15.92 | $15.62 | +250.31% |
| March, 2028 | $14.53 | $14.83 | $14.73 | +221.55% |
| April, 2028 | $15.54 | $14.07 | $14.01 | +243.83% |
| May, 2028 | $12.06 | $15.64 | $15.47 | +166.78% |
| June, 2028 | $8.3945 | $10.49 | $10.27 | +85.72% |
| July, 2028 | $6.792 | $8.0771 | $7.4475 | +50.27% |
| August, 2028 | $8.513 | $7.7685 | $7.5665 | +88.34% |
| September, 2028 | $9.204 | $9.524 | $9.079 | +103.63% |
| October, 2028 | $10.04 | $9.5355 | $10.08 | +122.16% |
| November, 2028 | $9.1774 | $9.8574 | $9.9312 | +103.04% |
| December, 2028 | $9.4034 | $9.7034 | $9.1319 | +108.04% |
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Price Forecast for 2029
The 2029 price forecast for Corbus Pharmaceuticals Holdings Inc Stock (CRBP) is $26.00 on average, with a high prediction of $49.12 and a low estimate of $2.8852. This represents an +475.30% increase from the previous price of $4.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $10.65 | $9.9294 | $9.5394 | +135.64% |
| February, 2029 | $10.98 | $10.74 | $10.66 | +142.85% |
| March, 2029 | $9.9828 | $9.3812 | $10.80 | +120.86% |
| April, 2029 | $9.0403 | $9.0288 | $9.1207 | +100.01% |
| May, 2029 | $12.02 | $2.8852 | $25.13 | +166.01% |
| June, 2029 | $16.48 | $5.5822 | $17.09 | +264.55% |
| July, 2029 | $25.16 | $16.01 | $35.65 | +456.64% |
| August, 2029 | $20.44 | $18.22 | $31.13 | +352.31% |
| September, 2029 | $31.47 | $20.75 | $32.77 | +596.20% |
| October, 2029 | $29.29 | $26.90 | $42.15 | +548.03% |
| November, 2029 | $45.08 | $28.59 | $48.26 | +897.45% |
| December, 2029 | $40.95 | $34.31 | $49.12 | +805.92% |
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Price Forecast for 2030
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) is expected to reach an average price of $24.77 in 2030, with a high forecast of $49.39 and a low forecast of $0.16. This signifies an +448.07% surge from the last price of $4.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $43.51 | $36.08 | $49.39 | +862.64% |
| February, 2030 | $7.1854 | $4.7699 | $44.70 | +58.97% |
| March, 2030 | $4.2094 | $4.1694 | $7.8939 | -6.87% |
| April, 2030 | $6.412 | $4.1734 | $9.1564 | +41.86% |
| May, 2030 | $1.616 | $1.3061 | $7.5505 | -64.25% |
| June, 2030 | $1.06 | $0.16 | $2.42 | -76.55% |
| July, 2030 | $2.3375 | $0.6815 | $1.7425 | -48.29% |
| August, 2030 | $4.4935 | $3.219 | $3.171 | -0.59% |
| September, 2030 | $3.8709 | $4.2209 | $4.6779 | -14.36% |
| October, 2030 | $3.1769 | $2.4954 | $1.8469 | -29.71% |
| November, 2030 | $0.1229 | $2.3029 | $2.1184 | -97.28% |
| December, 2030 | $1.3004 | $0.7244 | $1.6489 | -71.23% |
4.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):